Market Cap
$3.0B
FSK
FS KKR Capital Corp
$11.11 ▲ +1.09%
Prev close $10.99Market cap$3.0B
ConsensusSell
12-mo target$12.05 (+9.8%)
▼ Bearish
Analyst conviction 3/10
Insider Buying Cluster (2 insiders)High Impact Filing (8/10)12 New Institutional Positions27 Institutional Exits
Snapshot
The big-picture read on FSK right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Sell (27%)
Inst. Holders
50 funds
Inst. Value
$557.2M
Inst. Activity
12 buys / 27 sells
Insider Activity
$98.1K buy / $0.00 sell
Insider Net $
$98.1K
SEC Reports
18
Price chart 30d -9.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: FSK — 67.6% short (0.6M / 0.9M)
Short: 607,909 | Exempt: 4,205 | TRF Vol: 899,713 | Short Ratio: 67.6% | Off-exchange volume (dark p
Aug 31, 2026 Insider
Hopkins Jerel A bought 800 shares
Director @ $12.44 ($9.9K)
Aug 11, 2026 Insider
KROPP JAMES H bought 1,100 shares
Director @ $12.08 ($13.3K)
Jun 30, 2026 Inst.
VICTORY CAPITAL MANAGEMENT INC — DOUBLED
5,032,014 shares ($52.8M)
Jun 30, 2026 Inst.
Jun 29, 2026 SEC Russell Investments Group, Ltd. — ADD
1,587,876 shares ($16.7M)
FS KKR Capital Corp. closed its previously announced $150M issuance of 6,000,000 shares of Cumulative Convertible Perpet
8-K — Impact 6/10
FS KKR Capital Corp filed DEFA14A soliciting shareholder votes for its 2026 Annual Meeting on three proposals: electing
DEFA14A — Impact 2/10
FS KKR Capital Corp. completed a public offering of $900 million aggregate principal amount of 7.500% unsecured notes du
8-K — Impact 4/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
27% rate it Buy or better · 15 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 29, 2026 | Wells Fargo | DOWNGRADE | Underweight | 54% |
| Aug 19, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Aug 12, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
| Aug 7, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| May 12, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Apr 16, 2026 | Keefe, Bruyette & Woods | MAINTAIN | Market Perform | 58% |
| Apr 6, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
| Mar 13, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Mar 4, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Mar 3, 2026 | B. Riley Securities | MAINTAIN | Neutral | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| Aug 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| Jul 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| Jun 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| May 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| Apr 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| Mar 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% | |
| Feb 1, 2026 | 2 | 2 | 11 | 0 | 0 | 27% |
Price targets
Where 10 covering analysts think FSK trades over the next 12 months.
$12.05 +9.8% upside Buy
Current$10.97 Low$10.00 Median$12.00 High$15.00 10 analysts
$10.00$15.00
Analyst rating Hold· 3.0/5 as of Oct 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
18 SEC filing reports analyzed · 0 bullish, 3 bearish, 1 mixed, 14 neutral · avg impact 3.7/10.
MIXED8-K6/10
FS KKR Capital Corp. closed its previously announced $150M issuance of 6,000,000 shares of Cumulativ
Jun 29, 2026
NEUTRALDEFA14A2/10
FS KKR Capital Corp filed DEFA14A soliciting shareholder votes for its 2026 Annual Meeting on three
Jun 24, 2026
NEUTRAL8-K4/10
FS KKR Capital Corp. completed a public offering of $900 million aggregate principal amount of 7.500
Jun 8, 2026
BEARISH8-K6/10
FS KKR Capital Corp. priced a $900M offering of 7.500% Notes due 2031 via an underwriting agreement
Jun 2, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: FSK — 67.6% short (0.6M / 0.9M)
Short: 607,909 | Exempt: 4,205 | TRF Vol: 899,713 | Short Ratio: 67.6% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: FSK — 62.3% short (0.4M / 0.6M)
Short: 377,623 | Exempt: 900 | TRF Vol: 606,434 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: FSK — 61.1% short (0.5M / 0.8M)
Short: 506,860 | Exempt: 1,500 | TRF Vol: 829,588 | Short Ratio: 61.1% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: FSK — 59.7% short (0.3M / 0.5M)
Short: 315,705 | Exempt: 3,402 | TRF Vol: 529,177 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
Sep 18, 2026
short_volume
Short Volume: FSK — 63.2% short (0.5M / 0.8M)
Short: 515,757 | Exempt: 2,941 | TRF Vol: 815,502 | Short Ratio: 63.2% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Next Q | $0.37 | $0.31–$0.42 | -22.5% | -6.4% | 3↑ 5↓ | $0.3B | 11 |
| Current FY | $1.62 | $1.56–$1.70 | -30.6% | +0.2% | 5↑ 2↓ | $1.1B | 11 |
| Current Q | $0.41 | $0.38–$0.45 | -28.8% | -3.4% | 3↑ 5↓ | $0.3B | 11 |
| Next FY | $1.50 | $1.37–$1.70 | -7.5% | -0.7% | 4↑ 5↓ | $1.1B | 11 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.406 | — |
| 7d ago | $0.407 | -0.001 |
| 30d ago | $0.420 | -0.014 |
| 60d ago | $0.414 | -0.008 |
| 90d ago | $0.417 | -0.011 |
Institutional ownership
Which big funds own FSK (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $557.2M total value (53,032,951 shares) as of 2026-Q2. Top holders: UBS, VAN, VICTORY. Net selling activity: 27 institutions trimmed/exited vs 12 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| UBS Group AG | 5,760,510 | $60.5M | 10.9% | ADD +52.2% |
| VAN ECK ASSOCIATES CORP | 5,382,748 | $56.5M | 10.1% | — |
| VICTORY CAPITAL MANAGEMENT INC | 5,032,014 | $52.8M | 9.5% | DOUBLED +235.8% |
| LPL Financial LLC | 4,868,176 | $51.1M | 9.2% | — |
| MORGAN STANLEY | 2,877,758 | $30.2M | 5.4% | ADD +30.1% |
| Legal & General Group Plc | 2,735,984 | $28.7M | 5.2% | — |
| COMMONWEALTH EQUITY SERVICES, LLC | 1,928,826 | $20.3M | 3.6% | — |
| Russell Investments Group, Ltd. | 1,587,876 | $16.7M | 3.0% | ADD +52.5% |
| D. E. Shaw & Co., Inc. | 1,516,058 | $15.9M | 2.9% | TRIM -31.6% |
| Invesco Ltd. | 1,502,415 | $15.8M | 2.8% | ADD +85.2% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| VICTORY CAPITAL MANAGEMENT INC | DOUBLED | 1,498,474 | 5,032,014 | +235.8% | $52.8M |
| Russell Investments Group, Ltd. | ADD | 1,041,043 | 1,587,876 | +52.5% | $16.7M |
| D. E. Shaw & Co., Inc. | TRIM | 2,215,429 | 1,516,058 | -31.6% | $15.9M |
| Arax Advisory Partners | DOUBLED | 114,384 | 903,927 | +690.3% | $9.5M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 164,851 | 666,710 | +304.4% | $7.0M |
| Kestra Advisory Services, LLC | TRIM | 780,656 | 561,678 | -28.1% | $5.9M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | TRIM | 822,993 | 554,692 | -32.6% | $5.8M |
| NOMURA HOLDINGS INC | TRIM | 680,000 | 497,100 | -26.9% | $5.2M |
| Connor, Clark & Lunn Investment Management Ltd. | TRIM | 671,240 | 476,366 | -29.0% | $5.0M |
| AMERIPRISE FINANCIAL INC | TRIM | 782,337 | 366,777 | -53.1% | $3.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
3 insiders, 4 transactions. Net $98.1K — $98.1K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Hopkins Jerel A | Director | BUY | 800 | $12.44 | $9.9K |
| Aug 11, 2026 | KROPP JAMES H | Director | BUY | 1,100 | $12.08 | $13.3K |
| Feb 27, 2026 | Pietrzak Daniel | President and CIO | BUY | 5,000 | $11.25 | $56.3K |
| Feb 27, 2026 | KROPP JAMES H | Director | BUY | 1,666 | $11.16 | $18.6K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for FSK.
Shares short
14,084,411
Settlement Sep 15, 2026
Change vs prior
+9.1%
Semi-monthly cycle
Days to cover
9.1
At avg daily volume
Of shares outstanding
≈5.1%
Estimate — not % of float
All FSK filing & press-release reports (18)
- 8-K reportJun 29, 2026
- DEFA14A reportJun 24, 2026
- 8-K reportJun 8, 2026
- 8-K reportJun 2, 2026
- 8-K reportJun 2, 2026
- 8-K reportMay 18, 2026
- 8-K reportMay 12, 2026
- 8-K reportMay 11, 2026
- DEFA14A reportMay 5, 2026
- DEFA14A reportApr 30, 2026
- DEFA14A reportApr 30, 2026
- DEFA14A reportApr 30, 2026
- 8-K reportApr 28, 2026
- 8-K reportApr 21, 2026
- 8-K reportApr 10, 2026
- 8-K reportMar 5, 2026
- CLUSTER reportMar 3, 2026
- 8-K reportFeb 25, 2026